1259886

Suzhou Lixin Pharmaceutical Co. Ltd. — FEI 3008251350

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 30, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Suzhou (China)

Additional Details

Mutual Recognition Agreement (MRA)